Michael Buege, PharmD

My research interests are centered around (1) predicting and advancing clinical outcomes in patients with non-Hodgkin lymphomas, most especially mantle cell lymphoma in the post-BTK inhibitor setting, and (2) translation of preclinical and early clinical data on drug transporters, particularly solute carrier family transporters, to therapeutic exploitation of their function in patients with lymphoma.